|By PR Newswire||
|February 3, 2014 07:17 AM EST||
ELMSFORD, N.Y., Feb. 3, 2014 /PRNewswire/ -- BioScrip®, Inc. (NASDAQ: BIOS), today announced its proposal to commence an offering through a private placement, subject to market and other conditions, of $200 million in aggregate principal amount of senior notes due 2021. The notes will be senior unsecured obligations of BioScrip and will be guaranteed by certain of BioScrip's subsidiaries.
BioScrip intends to use the net proceeds of the offering to pay a portion of the amounts outstanding on its $75 million senior secured first-lien revolving credit facility, its $150 million senior secured first-lien delayed draw term B loan and its $250 million senior secured first-lien term loan B.
The notes and related guarantees are being offered in a private placement, solely to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to persons other than "U.S. persons" in compliance with Regulation S under the Securities Act. The notes and related guarantees have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
This notice does not constitute an offer to sell the notes, nor a solicitation for an offer to purchase the notes, in any jurisdiction in which such offer or solicitation would be unlawful. Any offer of the notes will be made only by means of a private offering memorandum. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.
About BioScrip, Inc.
BioScrip, Inc. provides comprehensive infusion and home care solutions. By partnering with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers, we are able to provide access to infusible medications and management solutions. Our goal is to optimize outcomes for chronic and other complex healthcare conditions and enhance the quality of patient life. BioScrip brings clinical competence in providing high-touch, comprehensive infusion and nursing services to patients in the most convenient ways possible. Through our customer services and treatments we aim to ensure the best possible therapy outcome.
SOURCE BioScrip, Inc.
StarNet Communications Corp has announced the addition of three Secure Remote Desktop modules to its flagship X-Win32 PC X server. The new modules enable X-Win32 to safely tunnel the remote desktops from Linux and Unix servers to the user’s PC over encrypted SSH. Traditionally, users of PC X servers deploy the XDMCP protocol to display remote desktop environments such as the Gnome and KDE desktops on Linux servers and the CDE environment on Solaris Unix machines. XDMCP is used primarily on comp...
Aug. 29, 2016 06:15 PM EDT Reads: 776
Aug. 29, 2016 06:15 PM EDT Reads: 248
Aug. 29, 2016 05:03 PM EDT Reads: 119
Aug. 29, 2016 04:30 PM EDT Reads: 3,561
Aug. 29, 2016 02:15 PM EDT Reads: 3,737
Aug. 29, 2016 02:00 PM EDT Reads: 983
Aug. 29, 2016 02:00 PM EDT Reads: 2,476
Aug. 29, 2016 12:45 PM EDT Reads: 2,020
Aug. 29, 2016 12:15 PM EDT Reads: 821
Aug. 29, 2016 12:00 PM EDT Reads: 871
Aug. 29, 2016 12:00 PM EDT Reads: 3,190
Aug. 29, 2016 12:00 PM EDT Reads: 826
Aug. 29, 2016 08:15 AM EDT Reads: 739
Aug. 29, 2016 08:00 AM EDT Reads: 945
Aug. 29, 2016 08:00 AM EDT Reads: 849